 |
MorphoSys AG
MOR
|
18.2 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Axsome Therapeutics
AXSM
|
174 |
$ 164.05 |
- |
$ 8.16 B |
USA |
 |
Graybug Vision
GRAY
|
0.44 |
- |
-11.23 % |
$ 9.65 M |
USA |
 |
Apellis Pharmaceuticals
APLS
|
22 |
$ 20.16 |
- |
$ 2.54 B |
USA |
 |
Aptorum Group Limited
APM
|
0.75 |
$ 0.79 |
- |
$ 4.31 M |
China |
 |
I-Mab
IMAB
|
0.68 |
- |
- |
$ 866 M |
China |
 |
Acer Therapeutics
ACER
|
0.77 |
- |
2.71 % |
$ 14 M |
USA |
 |
Biophytis SA
BPTS
|
0.33 |
- |
-13.47 % |
$ 169 M |
France |
 |
BioMarin Pharmaceutical
BMRN
|
61 |
$ 58.53 |
- |
$ 11.2 B |
USA |
 |
Ampio Pharmaceuticals
AMPE
|
0.82 |
- |
-11.43 % |
$ 502 K |
USA |
 |
AbCellera Biologics
ABCL
|
3.22 |
$ 3.71 |
- |
$ 1.11 B |
Canada |
 |
Athersys
ATHX
|
0.9 |
- |
3.77 % |
$ 22.4 M |
USA |
 |
Midatech Pharma plc
MTP
|
0.29 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
AVEO Pharmaceuticals
AVEO
|
3.54 |
- |
- |
$ 521 M |
USA |
 |
Brainstorm Cell Therapeutics
BCLI
|
1.26 |
- |
-2.5 % |
$ 5.88 M |
USA |
 |
BioDelivery Sciences International
BDSI
|
3.1 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Burford Capital Limited
BUR
|
10.6 |
$ 8.55 |
- |
$ 1.38 B |
Britain |
 |
Capricor Therapeutics
CAPR
|
5.8 |
$ 25.84 |
- |
$ 692 M |
USA |
 |
BridgeBio Pharma
BBIO
|
68.4 |
$ 64.53 |
- |
$ 12.4 B |
USA |
 |
Adverum Biotechnologies
ADVM
|
3.86 |
- |
- |
$ 86.2 M |
USA |
 |
CymaBay Therapeutics
CBAY
|
32.3 |
- |
- |
$ 3.45 B |
USA |
 |
Avid Bioservices
CDMO
|
6.7 |
- |
- |
$ 789 M |
USA |
 |
Codexis
CDXS
|
3.97 |
$ 0.98 |
-3.92 % |
$ 71.9 M |
USA |
 |
Certara
CERT
|
6.72 |
$ 7.24 |
- |
$ 1.16 B |
USA |
 |
ARCA biopharma
ABIO
|
28.8 |
- |
1052.0 % |
$ 415 M |
USA |
 |
Checkpoint Therapeutics
CKPT
|
4.04 |
- |
- |
$ 169 M |
USA |
 |
Caladrius Biosciences
CLBS
|
0.43 |
- |
-16.75 % |
$ 25.8 M |
USA |
 |
Alpine Immune Sciences
ALPN
|
8.04 |
- |
- |
$ 2.17 B |
USA |
 |
Clovis Oncology
CLVS
|
2.04 |
- |
-7.23 % |
$ 13 M |
USA |
 |
Acorda Therapeutics
ACOR
|
13.5 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Checkmate Pharmaceuticals
CMPI
|
2.44 |
- |
- |
$ 231 M |
USA |
 |
Coherus BioSciences
CHRS
|
2.22 |
$ 1.65 |
- |
$ 155 M |
USA |
 |
Acasti Pharma
ACST
|
3.37 |
- |
4.01 % |
$ 150 M |
Canada |
 |
CTI BioPharma Corp.
CTIC
|
4.8 |
- |
- |
$ 1.2 B |
USA |
 |
CohBar
CWBR
|
1.83 |
- |
-15.44 % |
$ 2.2 M |
USA |
 |
Cyclacel Pharmaceuticals
CYCC
|
0.25 |
- |
-5.98 % |
$ 34.1 M |
USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
4.9 |
- |
-4.36 % |
$ 27 M |
USA |
 |
Cabaletta Bio
CABA
|
17.5 |
$ 3.25 |
- |
$ 3.8 M |
USA |
 |
Deciphera Pharmaceuticals
DCPH
|
14.1 |
- |
- |
$ 2.18 B |
USA |
 |
CureVac N.V.
CVAC
|
19.3 |
- |
- |
$ 867 M |
Germany |
 |
Aeterna Zentaris
AEZS
|
5.72 |
- |
5.93 % |
$ 314 M |
Canada |
 |
Corvus Pharmaceuticals
CRVS
|
1.96 |
$ 17.53 |
- |
$ 842 M |
USA |
 |
AgeX Therapeutics
AGE
|
13 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
12 |
- |
- |
$ 1.01 B |
USA |
 |
Entasis Therapeutics Holdings
ETTX
|
1.7 |
- |
- |
$ 105 M |
USA |
 |
Evofem Biosciences
EVFM
|
0.8 |
- |
7.55 % |
$ 38.1 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.3 |
- |
- |
$ 26.5 M |
USA |